Cardinal Health, Inc. $CAH Shares Sold by Danske Bank A S

Key Points

• Danske Bank A/S trimmed its stake in Cardinal Health by 13.6%, selling 24,992 shares and leaving it with 158,605 shares (about 0.07% of the company) valued at roughly $32.6 million.
• Q3 was mixed: Cardinal Health beat non‑GAAP EPS ($3.17 vs. $2.79), raised FY‑2026 guidance to $10.70–$10.80 and added $250M in buybacks, but revenue missed expectations ($60.94B vs. ~$62.10B) and a $184M pre‑tax goodwill impairment weakened GAAP results.
• Analyst sentiment is cautiously positive with a consensus "Moderate Buy" and a $243.67 target; notable divergence includes Jefferies raising its target to $270 while Citigroup trimmed its target to $245.

Danske Bank A S trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 13.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 158,605 shares of the company's stock after selling 24,992 shares during the period. Danske Bank A S owned approximately 0.07% of Cardinal Health worth $32,593,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of CAH. Integrated Wealth Concepts LLC boosted its stake in Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock valued at $601,000 after acquiring an additional 280 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in Cardinal Health in the second quarter valued at approximately $1,935,000. Cerity Partners LLC boosted its stake in Cardinal Health by 17.0% in the second quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock valued at $6,792,000 after acquiring an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC boosted its stake in Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock valued at $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CAH. Citigroup lowered their target price on shares of Cardinal Health from $249.00 to $245.00 and set a "buy" rating for the company in a research note on Friday. Jefferies Financial Group raised their target price on shares of Cardinal Health from $220.00 to $270.00 and gave the company a "buy" rating in a research note on Thursday, January 22nd. Weiss Ratings restated a "buy (b)" rating on shares of Cardinal Health in a research note on Monday, April 20th. Morgan Stanley lifted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an "overweight" rating in a research note on Tuesday. Finally, Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $243.67.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Price Performance

NYSE CAH opened at $195.13 on Friday. The company has a market capitalization of $45.92 billion, a PE ratio of 28.08, a P/E/G ratio of 1.19 and a beta of 0.53. The company has a fifty day moving average of $213.73 and a 200 day moving average of $205.46. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm's quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts expect that Cardinal Health, Inc. will post 10.79 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were given a dividend of $0.5107 per share. The ex-dividend date was Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health's payout ratio is currently 29.35%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.